Posted by Michael Wonder on 06 Jun 2017
AMA will vote on requiring drug makers to disclose prices in consumer ads
6 June 2017 - In its latest bid to restrain pharmaceutical advertising, the American Medical Association will vote on a resolution to demand that drug makers disclose pricing in ads that are aimed at consumers.
The proposal, which will be heard at the annual AMA meeting next week in Chicago, was made in response to concerns over rising drug costs and an unsuccessful bid by the medical organisation to convince Congress to ban so-called direct-to-consumer advertising altogether.
